Witryna5 kwi 2024 · Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (" Innate " or the " Company ") today announced the filing of its 2024 Universal Registration Document ( … WitrynaGet the latest BBC World News: international news, features and analysis from Africa, the Asia-Pacific, Europe, Latin America, the Middle East, South Asia, and the United …
Innate Pharma reports first half 2024 financial results and business ...
Witryna6 kwi 2024 · MARSEILLE, France, April 06, 2024--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced the filing of its 2024 Universal Registration Document (Document ... Witryna16 sty 2024 · MARSEILLE, France, January 16, 2024--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") announced today the publication in Nature Biotechnology of preclinical data showing the control of acute myeloid leukemia (AML) cells by a trifunctional NKp46-CD16a-NK cell engager … javi balboa madrid
SVB Securities Keeps Their Buy Rating on Innate Pharma (IPHA)
Witryna10 kwi 2024 · Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ('Innate' or the 'Company') will hold its Annual General Meeting of Shareholders ('AGM') at 10:30 a.m. CEST on May 12, 2024 in its headquarters, 117 avenue de Luminy, F-13009 Marseille.. The Annual General Meeting will be broadcasted live. The Notice of Meeting of this … Witryna29 kwi 2024 · Investors and Media Innate Pharma Henry Wheeler Tel.: +33 484 90 32 88 [email protected] ATCG Press Marie Puvieux (France) Tel.: +33 (0)9 81 87 46 72 innate-pharma@atcg … Witryna13 mar 2024 · Innate Pharma does not have any financial exposure to Silicon Valley Bank. MARSEILLE, France, March 13, 2024--(BUSINESS WIRE)--Regulatory News:. Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA ... javi balboa sueldo